Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2024-12-10 00:00:00 ET · period of report 2024-12-06 · accession 0001437749-24-037138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-10 | 2024-12-06 | LMAT | Jasinski Lawrence J | Dir | A - Grant | $0.00 | +420 | 5,531 | +8% | $0 |
| D | 2024-12-10 | 2024-12-06 | LMAT | Jasinski Lawrence J | Dir | A - Grant | $0.00 | +2,594 | 2,594 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-06 | A | A | 420 | $0.00 | 5,531 | D | — | — | (F1) Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-12-06 | A | A | 2,594 | $0.00 | 2,594 | D | $101.12 · 2024-12-06 to 2029-12-06 | 2,594 Common Stock | (F2) This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. |